Herald Sun
Australia
October 31, 2011
A MELBOURNE woman who suffered an auto-immune and neurological attack after being injected with the cervical cancer vaccine Gardasil is leading a class action against its manufacturer.
Seven other Victorian women who are considering joining the court case against Merck say they have suffered anaphylaxis and physical breakdowns as a result of the vaccine. One has attributed a miscarriage to the injections.
Naomi Snell, 28, said her life was put on hold for more than two years after she lost the ability to walk, battled crippling back and neck pain, and suffered convulsions that started soon after her first injection in July 2008.
“I never attributed it to my vaccine so I went back for my second and third dose,” she said. “My doctors were baffled. They did diagnose me with multiple sclerosis, but have since retracted that and said it was a neurological reaction to the vaccine.”
The world’s first cancer vaccine, created by former Australian of the year Prof Ian Frazer, has been hailed as a wonder drug for protecting against 70 per cent of cervical cancers.
A Federal Government campaign to have every Australian woman aged 12 to 26 vaccinated included free inoculations.
Ms Snell is seeking compensation for loss of income and medical expenses.
HPV has been found in placenta, umbilical cord, infants and in sexually abused children. So what are the vaccine promoters’ reasons for vaccinating thousands of girls with Gardasil before sexual debut? To sell the vaccine to very large groups?
http://content.karger.com/ProdukteDB/produkte.asp?Doi=24939
Summary
“There is now compelling evidence that persistent infection with certain types of human genital papillomaviruses (HPV) may, after many years, lead to cervical cancer. However, HPV have been detected in asymptomatic women, infants and children.
Several studies have demonstrated that infants can acquire high-risk HPV infections from their mothers at birth. Thus, the traditional view that cervical-cancer associated HPV infections are primarily sexually transmitted needs to be re-assessed. Accordingly, the role of mother to child transmission of cancer-associated HPVs may need to be investigated further. These facts are pertinent to those developing prophylactic vaccines to prevent high-risk HPV infections and cervical carcinoma”.
Quote from SANE Vax:
“SANE Vax Inc. is tired of the rhetoric surrounding the HPV vaccine issue. Peer-reviewed analysis and studies many of them on the FDA, NCI and CDC web sites point out the dangers of many of the vaccine ingredients including the potential for the HPV vaccines to increase the risk for pre-cancerous lesions if adolescents have been previously exposed to the human papillomavirus and then get vaccinated: 44.6% increase post Gardasil; 32.5% post Cervarix”.
Is it not ethically extremely dubious that these vaccines are being advised for an unknown number, possibly very many, who already have HPV infection?